4.6 Review

Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbcan.2009.01.001

关键词

Carbonic anhydrase IX; Transcriptional regulation; Hypoxia; Hypoxia-inducible factor

资金

  1. NIH [R01 CA104214]

向作者/读者索取更多资源

Transcriptional activation by hypoxia is mediated by the hypoxia-inducible factor (HIF) via binding to the hypoxia-responsive element (HRE). Hypoxia in solid tumors associates with poorer outcome of the disease and reliable cellular markers of tumor hypoxia would represent a valuable diagnostic marker and a potential therapeutic target. In this category, carbonic anhydrase IX (CAIX) is one of the most promising candidates. Here, we summarize the knowledge about transcriptional regulation of CA9. The HRE is the central regulatory element in the CA9 promoter, whereas other elements are limited to lesser roles of amplification of signals received at the HRE. The analysis of known mechanisms of activation of C49 reveals the prominent role of the HIF-1 pathway. Experimental paradigms with uncoupled HIF-1 alpha stability and transcriptional activity (pericellular hypoxia, proteasomal inhibitor) provide evidence that CA9 expression monitors transcriptional activity of HIF-1, rather than the abundance of HIF-1 alpha. Furthermore, these paradigms could provide a corollary to some of the apparently discordant cases (CAIX+, HIF-1 alpha-) or (CAIX-, HIF-1 alpha+) observed in vivo. In conclusion, the existing data support the notion that CA9, due to the unique structure of its promoter, is one of the most sensitive endogenous sensors of HIF-1 activity. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A role for activated Cdc42 in glioblastoma multiforme invasion

Hidehiro Okura, Brian J. Golbourn, Uswa Shahzad, Sameer Agnihotri, Nesrin Sabha, Jonathan R. Krieger, Carlyn A. Figueiredo, Alan Chalil, Natalie Landon-Brace, Alexandra Riemenschneider, Hajime Arai, Christian A. Smith, Songli Xu, Stefan Kaluz, Adam I. Marcus, Erwin G. Van Meir, James T. Rutka

ONCOTARGET (2016)

Article Oncology

A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis

Xin Dai, Stefan Kaluz, Ying Jiang, Lei Shi, DeAngelo Mckinley, Yingzhe Wang, Binghe Wang, Erwin G. Van Meir, Chalet Tan

ONCOTARGET (2017)

Editorial Material Cell Biology

Taking a HIF pill for old age diseases?

Stefan Kaluz, Chalet Tan, Erwin G. Van Meir

AGING-US (2018)

Article Chemistry, Medicinal

Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors

Chalet Tan, Rita G. de Noronha, Narra S. Devi, Adnan A. Jabbar, Stefan Kaluz, Yuan Liu, Suazette Reid Mooring, K. C. Nicolaou, Binghe Wang, Erwin G. Van Meir

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Oncology

PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines

Norazizah Shafee, Stefan Kaluz, Ning Ru, Eric J. Stanbridge

CANCER LETTERS (2009)

Article Oncology

Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

Shaoman Yin, Stefan Kaluz, Narra S. Devi, Adnan A. Jabbar, Rita G. de Noronha, Jiyoung Mun, Zhaobin Zhang, Purushotham R. Boreddy, Wei Wang, Zhibo Wang, Thomas Abbruscato, Zhengjia Chen, Jeffrey J. Olson, Ruiwen Zhang, Mark M. Goodman, K. C. Nicolaou, Erwin G. Van Meir

CLINICAL CANCER RESEARCH (2012)

Review Chemistry, Medicinal

Hypoxia inducible factor pathway inhibitors as anticancer therapeutics

Sarah K. Burroughs, Stefan Kaluz, Danzhu Wang, Ke Wang, Erwin G. Van Meir, Binghe Wang

FUTURE MEDICINAL CHEMISTRY (2013)

Article Chemistry, Medicinal

Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway

Suazette Reid Mooring, Hui Jin, Narra S. Devi, Adnan A. Jabbar, Stefan Kaluz, Yuan Liu, Erwin G. Van Meir, Binghe Wang

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Editorial Material Genetics & Heredity

At the crossroads of cancer and inflammation: Ras rewires an HIF-driven IL-1 autocrine loop

Stefan Kaluz, Erwin G. Van Meir

JOURNAL OF MOLECULAR MEDICINE-JMM (2011)

Article Biochemistry & Molecular Biology

Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex

Jun Fan, Changliang Shan, Hee-Bum Kang, Shannon Elf, Jianxin Xie, Meghan Tucker, Ting-Lei Gu, Mike Aguiar, Scott Lonning, Huaibin Chen, Moosa Mohammadi, Laura-Mae P. Britton, Benjamin A. Garcia, Masa Aleckovic, Yibin Kang, Stefan Kaluz, Nara Devi, Erwin G. Van Meir, Taro Hitosugi, Jae Ho Seo, Sagar Lonial, Manila Gaddh, Martha Arellano, Hanna J. Khoury, Fadlo R. Khuri, Titus J. Boggon, Sumin Kang, Jing Chen

MOLECULAR CELL (2014)

Article Biochemistry & Molecular Biology

A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1

S. M. Cork, B. Kaur, N. S. Devi, L. Cooper, J. H. Saltz, E. M. Sandberg, S. Kaluz, E. G. Van Meir

ONCOGENE (2012)

Article Chemistry, Medicinal

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor

Qi Shi, Shaoman Yin, Stefan Kaluz, Nanting Ni, Narra Sarojini Devi, Jiyoung Mun, Danzhu Wang, Krishna Damera, Weixuan Chen, Sarah Burroughs, Suazette Reid Mooring, Mark M. Goodman, Erwin G. Van Meir, Binghe Wang, James P. Snyder

ACS MEDICINAL CHEMISTRY LETTERS (2012)

Article Oncology

Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma

Lei Dong, Shuo You, Qing Zhang, Satoru Osuka, Narra S. Devi, Stefan Kaluz, Jalisa H. Ferguson, Hua Yang, Guoliang Chen, Binghe Wang, Hans E. Grossniklaus, Erwin G. Van Meir

CLINICAL CANCER RESEARCH (2019)

暂无数据